RESUMEN
CONTEXT: Cancer registries have reported an increased incidence of melanoma and certain noncutaneous cancers following nonmelanoma skin cancer (NMSC). Whether these findings were attributable to intensified surveillance, shared risk factors, or increased cancer susceptibility remains unclear. OBJECTIVE: To determine whether a history of NMSC predicts cancer mortality. DESIGN: Prospective cohort with 12-year mortality follow-up adjusted for multiple risk factors. SETTING: Cancer Prevention Study II, United States and Puerto Rico. PARTICIPANTS: Nearly 1.1 million adult volunteers who completed a baseline questionnaire in 1982. MAIN OUTCOME MEASURE: Deaths due to all cancers and common cancers. RESULTS: After adjusting for age, race, education, smoking, obesity, alcohol use, and other conventional risk factors, a baseline history of NMSC was associated with increased total cancer mortality (men's relative risk [RR], 1.30; 95% confidence interval [CI], 1.23-1.36; women's RR, 1.26; 95% CI, 1.17-1.35). Exclusion of deaths due to melanoma reduced these RRs only slightly. Mortality was increased for the following cancers: melanoma (RR, 3.36 in men, 3.52 in women); pharynx (RR, 2.77 in men, 2.81 in women); lung (RR, 1.37 in men, 1.46 in women); non-Hodgkin lymphoma (RR, 1.32 in men, 1.50 in women); in men only, salivary glands (RR, 2.96), prostate (RR, 1.28), testis (RR, 12.7), urinary bladder (RR, 1.41), and leukemia (RR, 1.37); and in women only, breast (RR, 1.34). All-cause mortality was slightly increased (adjusted men's RR, 1.03 [95% CI, 1.00-1.06]; women's RR, 1.04 [95% CI, 1.00-1.09]). CONCLUSIONS: Persons with a history of NMSC are at increased risk of cancer mortality. Although the biological mechanisms are unknown, a history of NMSC should increase the clinician's alertness for certain noncutaneous cancers as well as melanoma.
Asunto(s)
Neoplasias/mortalidad , Neoplasias Cutáneas/mortalidad , Anciano , Femenino , Humanos , Masculino , Persona de Mediana Edad , Modelos de Riesgos Proporcionales , Estudios Prospectivos , Puerto Rico/epidemiología , Factores de Riesgo , Estados Unidos/epidemiologíaRESUMEN
In a mail survey of physicians likely to be involved with intrauterine contraception in the United States and Puerto Rico, 49.2% of the physicians responded, describing 3,502 unduplicated reports of hospitalizations related to the use of intrauterine contraceptive devices (IUDs) during the first six months of 1973. We estimate from this response that approximately 7,900 IUD-related hospitalizations occurred during that period. Interviews with a probability sample of nonrespondents demonstrated that their IUD complication experience was not substantially different from that reported through the mail survey. Estimates of the number of IUDs worn in 1973 permit rate calculations of three to ten IUD-related hospitalizations per 1,000 woman-years of IUD use. The rate of hospitalizations attributable to the IUD is probably higher that that attributable to combination oral contraceptives.
Asunto(s)
Hospitalización , Dispositivos Intrauterinos/efectos adversos , Adolescente , Adulto , Femenino , Humanos , Embarazo , Complicaciones del Embarazo , Puerto Rico , Encuestas y Cuestionarios , Estados UnidosRESUMEN
PIP: Retrospective reports on IUD insertions during the first 6 months of 1973 were provided by 16,893 physicians residing in the U.S. and Puerto Rico. This was 48.9% of the physicians listed in the master files of the American Medical Association and the American Osteopathic Association as having an interest in obstetrics and gynecology, public health, general preventive medicine, or family practice. Information elicited by interviews with 1% of the nonrespondents mirrored that of the respondents. It is estimated that in the 6-month period there were 810,000 IUD insertions. Regional rates varied from a high of 27.3/1000 in parts of the West to 11.8-12.4/1000 in the Midwest. The rate for the nation was 18/1000. The percentage of nonprivate patients receiving IUDs varied substantially by region, too. 85% of all insertions were do ne by physicians; 6% by paramedical personnel. 90% of the physician-inserted IUDs were by doctors whose primary specialty was obstetrics-gynecology and more than 75% were by doctors engaged in direct patient care. Rates of insertion by individual physicians varied greatly. 1% of the obstetricians-gynecologists averaged more than 8 insertions a week.^ieng